Ocular Immunology and Uveitis Foundation - Uveitis is the third
Uveitis PDF
Transcript of Uveitis PDF
K. Kazemi Zand
Ophthalmologist
Semnan University of Medical Sciences
Definition Uveitis is a condition that involves inflammation of
the uveal tract (iris, ciliary body, choroid) or adjacent ocular structures (retina, optic nerve, vitreous, sclera).
Anatomical Classification Type Primary Site of
Inflammation Includes
Anterior uveitis Anterior chamber Iritis/iridocyclitis/anterior cyclitis
Intermediate uveitis Vitreous Pars planitis/posterior cyclitis/hyalitis
Posterior uveitis Choroid Focal, multifocal, or diffuse choroiditis/chorioretinitis/retinochoroiditis/retinitis/Neuroretinitis
Panuveitis Anterior chamber, vitreous, and/or choroid
Further Classification Onset (sudden or insidious)
Duration (limited — less than 3 months duration, or persistent — more than 3 months duration)
Course (acute, recurrent, or chronic)
Laterality (unilateral or bilateral)
Etiology
The most common etiology of uveitis is idiopathic.
A wide variety of infectious, traumatic, autoimmune
or neoplastic mechanisms are known to promote or
trigger uveitis.
Systemic disorders associated with uveitis Seronegative spondylarthropathies (Ankylosing spondylitis, Reiter’s
syndrome, Inflammatory bowel disease, psoriatic arthropathy)
Behçet’s disease
Systemic lupus erythematosus
Juvenile rheumatoid arthritis
Multiple sclerosis
Chronic granulomatous disorders (tuberculosis, sarcoidosis)
Herpes simplex/zoster
Syphilis
Toxoplasmosis
Brucellosis
HIV infection
……
Epidemiology • Age
• The majority of patients are aged 20-50 years.
• Race • Racial predisposition to uveitis is related to the patient's
underlying systemic disease. • Caucasian: HLA-B27 related diseases, multiple sclerosis
• African American: Sarcoidosis, SLE
• Mediterranean/Middle Eastern: Behçet's disease (HLA-B5)
• Sex • In general, uveitis does not have a gender predisposition
except in cases secondary to systemic disease, such as JRA and SLE
The most common type of uveitis presented to the emergency department is “Acute Anterior Uveitis”.
Clinical Presentation
Symptoms:
Red eye
Pain
Blurred vision
Photophobia
Excessive tearing
Clinical Presentation
Signs: Perilimbal injection
Direct and consensual photophobia
Pupillary miosis (common but not always present)
Keratic precipitates on corneal endothelium (granulomatous or non-granulomatous)
Marked cell and flare reaction in the anterior chamber (WBC,
RBC, protein)
Hypopyon (seen in Behçet’s disease & endophthalmitis)
Various degrees of posterior synechiae (Iris bombé pupillary block glaucoma)
Differential Diagnosis
Consider all other causes of a red eye before uveitis is diagnosed.
Acute conjunctivitis
Corneal abrasion or ulceration
Ultraviolet keratitis
Foreign body
Acute angle-closure glaucoma
Scleritis
Workup & evaluation Lab studies are not part of the emergency management of uveitis.
Lab workup is not necessary in all cases. (e.g. a mild, unilateral non-
granulomatous uveitis or a known predisposing systemic disease)
Indications for requesting lab studies:
Unremarkable history and physical examination
Bilateral uveitis
Granulomatous uveitis
Recurrent uveitis
Lab studies should be individualized according to clinical suspicion. Not all workups are necessary for all patients.
Lab studies CBC, ESR (non-specific)
ANA (autoimmune disorders)
Serum ACE, lysosyme (Sarcoidosis)
HLA-B27 (seronegative spondyloarthropathies)
HLA-B5 (Behçet’s disease)
VDRL, RPR, FTA-ABS (Syphilis)
PPD (Tuberculosis, Sarcoidosis)
HIV antibody (AIDS)
Imaging studies Chest X-ray is indicated if tuberculosis or sarcoidosis is
considered.
Sacroiliac X-ray is indicated if HLA-B27 related diseases are suspected.
Brain MRI may be needed if multiple sclerosis is a
possibility.(intermediate uveitis)
Fluorescein angiography or ocular sonography may be needed in certain types of posterior uveitis
Medical management Corticosteroids (topical, periocular and/or systemic use)
Reduces active inflammation in the eye
Prevents and treats uveitis complications
Beware of drug complications (cataract, glaucoma, HSV keratitis)
Cycloplegics (Homatropine, cyclopentolate,...)
Relief of pain and photophobia
Breaking posterior synechiae/ pupillary block
Immunosuppressive therapy (methotrexate, cyclophosphamide,…)
Severe uveitis
Unresponsive to corticosteroids
Severe corticosteroid induced complications
Follow up Refer the patient to an ophthalmologist within 24
hours
Cases of uveitis should be monitored every 1-7 days in the acute phase
Steroids and cycloplegics should be tapered and not discontinued suddenly
When the condition is stable, patients are monitored every 1-6 months